HPG1860

· Hepagene (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HPG1860, covering 2022-09-16 to 2022-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2a Study of HPG1860 in Subjects With NASH [Phase 2]